Chart calendar ArriVent BioPharma, Inc.

7c1c2497.JxAceBqYeUDlWQBbA_JmJW3BWxOaYEwQNvTUCves8Y8.Hl5ZCSvwLzOKFWwDLsUvbguUHSXTKBQiUrO7Tb_inMJmZkseTcpPJsg9cw~31b05ba4137dccea7ff7fecf42d7fa02

Upcoming events on ArriVent BioPharma, Inc.

No events available

Past events on ArriVent BioPharma, Inc.

2025-06-23

Information meeting

 08:00 am
2025-06-18

Présentation aux Actionnaires / Analystes

 12:00 pm
2025-06-17

Annual General Meeting

Day

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
0,00
-2,50
-
0,00
0,00
-
0,00
0,00
-

0,00


36,4


124

EBITDA
Million USD
Released
Forecast
Spread
-74,6
-73,3
-1.82%
-94,3
-96,9
2.68%
-178
-155
-14.76%

-180


-168


-84,0

EBIT
Million USD
Released
Forecast
Spread
-74,6
-67,6
-10.39%
-94,3
-98,3
4.07%
-178
-174
-2.07%

-177


-167


-88,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-69,3
-61,3
-13.18%
-80,5
-84,7
4.92%
-166
-166
-0.16%

-167


-158


-83,3

Net income
Million USD
Released
Forecast
Spread
-69,3
-61,3
-13.18%
-80,5
-84,7
4.92%
-166
-166
-0.19%

-167


-158


-84,2

EPS
USD
Released
Forecast
Spread
-32,4
-11,3
-186.39%
-2,56
-2,74
6.57%
-4,32
-4,37
1.17%

-3,69


-3,19


-1,48

Announcement Date28/03/2403/03/2505/03/26-

Quarterly results

Fiscal PeriodDecember 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


20,1


20,1


20,1


20,1

EBITDA
Million USD
Released
Forecast
Spread
-25,7
-21,6
-19.1%
-24,2
-26,8
9.73%
-23,7
-26,3
9.88%






-38,3
-29,2
-31.35%
-38,8
-39,5
1.7%

-41,5


-46,7


-48,9


-50,1













EBIT
Million USD
Released
Forecast
Spread
-25,7
-22,3
-15.04%
-24,2
-35,2
31.07%
-23,7
-27,7
14.45%
-66,8
-26,0
-157.28%
-33,6
-26,8
-25.23%
-38,3
-34,2
-11.95%
-38,8
-39,9
2.66%

-40,9


-41,7


-45,6


-50,6


-32,2


-32,2


-32,2


-32,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-21,9
-18,8
-16.28%
-20,6
-23,2
11.22%
-20,6
-24,8
16.75%
-64,4
-22,7
-183.92%
-31,4
-24,0
-30.96%
-35,0
-32,5
-7.6%
-35,5
-35,3
-0.8%

-38,3


-38,6


-42,9


-48,6


-32,2


-32,2


-32,2


-32,2

Net income
Million USD
Released
Forecast
Spread
-21,9
-18,8
-16.28%
-20,6
-23,2
11.22%
-20,6
-24,8
16.75%
-64,4
-22,7
-183.92%
-31,4
-24,0
-30.96%
-35,0
-32,5
-7.6%
-35,5
-35,3
-0.66%

-38,3


-38,6


-42,9


-48,6


-32,2


-32,2


-32,2


-32,2

EPS
USD
Released
Forecast
Spread
-0,65
-0,61
-7.28%
-0,61
-0,82
25.61%
-0,61
-0,78
22.04%
-1,90
-0,66
-186.14%
-0,90
-0,70
-29.1%
-0,83
-0,81
-2.83%
-0,78
-0,83
6.02%

-0,86


-0,86


-0,93


-1,03


-0,73


-0,73


-0,73


-0,72

Announcement Date14/08/2414/11/2403/03/2512/05/2511/08/2510/11/2505/03/26--------
2026-04-12

Earnings presentation

 10:00 pm
2026-04-13

Information meeting

 08:00 am
2026-04-13

Information meeting

 08:30 am
2026-04-13

Sales and Revenue Release - Q1 2026

Day
2026-04-14

Earnings release - Annual 2025

~ 09:30 pm
2026-04-15

Annual General Meeting

 05:00 am
2026-04-17

Earnings presentation

 02:00 am
2026-04-17

Information meeting

 10:30 am
2026-04-17

Annual General Meeting

 12:00 am
2026-04-17

Earnings release - Annual 2025

~ 09:30 pm

Past sector events for ArriVent BioPharma, Inc.

2026-04-06

Board of Directors Meeting

Day
2026-03-31

Information meeting

 08:00 am
2026-03-31

Earnings presentation

 03:00 am
2026-03-30

Annual General Meeting

 08:01 pm
2026-03-30

Earnings release - Annual 2025

~ 09:30 pm
2026-03-30

Board of Directors Meeting

Day
2026-03-31

Earnings release - Annual 2025

~ 04:00 am
2026-03-30

Annual General Meeting

Day
2026-03-31

Earnings presentation

 08:30 am
2026-03-31

Earnings release - Annual 2025

~ 09:30 am

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AVBP Stock
  4. Calendar ArriVent BioPharma, Inc.